渗出性年龄相关性黄斑变性伴黄斑积液患者白内障手术结局
回顾性队列研究纳入2012年1月1日至2016年12月31日期间接受白内障手术且术前6个月内因渗出性AMD接受过至少1次玻璃体腔抗VEGF注射的81眼,比较术前OCT有黄斑积液(23眼)与无积液患者的术后视力与解剖结局。结果显示全体患者最佳矫正视力显著改善(P<.0001),黄斑中心凹厚度无显著变化(P>.05);有积液组与无积液组最终视力、厚度及术后积液发生率均无差异(P均>.05),有积液组视力亦显著改善(P=.006)。
要点
- 渗出性AMD伴黄斑积液患者白内障术后视力显著改善(P=.006),新生血管过程无恶化。
- 术前OCT有黄斑积液者与无积液者术后最终视力、黄斑中心凹厚度及积液发生率无显著差异(P均>.05)。
- 全体患者术后最佳矫正视力较术前显著改善(P<.0001),黄斑中心凹厚度无显著变化(P>.05)。
核心结论
- 在真实世界环境中,同时患有白内障和湿性AMD的患者可安全接受白内障手术。
- 术前OCT显示黄斑积液稳定的患者可考虑行白内障手术,因其术后结局良好且新生血管过程无恶化。
研究设计与样本
- 回顾性队列研究,纳入2012年1月1日至2016年12月31日期间接受白内障手术且术前6个月内因渗出性AMD接受过至少1次玻璃体腔抗VEGF注射的患者,共81眼。
主要发现
- 全体患者术后最佳矫正视力较术前显著改善(P<.0001),黄斑中心凹厚度术前与术后无显著差异(P>.05)。
- 术前OCT有黄斑积液者23眼,其术后最终最佳矫正视力、黄斑中心凹厚度及术后积液发生率与术前无积液者相比均无显著差异(P均>.05)。
- 术前有黄斑积液者术后最佳矫正视力亦显著改善(P=.006)。
临床怎么用
- 作者认为,同时患有白内障和湿性AMD的患者可安全接受白内障手术。
- 作者认为,术前OCT显示黄斑积液稳定的患者可考虑行白内障手术。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To investigate whether having macular fluid on optical coherence tomography (OCT) prior to cataract surgery adversely affected vision or anatomic outcomes after cataract surgery in patients with exudative age-related macular degeneration (AMD). DESIGN: Retrospective cohort study. METHODS: We examined all patients who underwent cataract surgery and were receiving intravitreal anti-vascular endothelial growth factor (anti-VEGF) injections from January 1, 2012 through December 31, 2016. There were 81 eyes that underwent cataract surgery and had received at least 1 intravitreal anti-VEGF injection for a diagnosis of exudative AMD within 6 months prior to surgery. Data collected included the development of subretinal or intraretinal macular fluid, or subretinal hemorrhage, in the 6 months following surgery; number of injections; best-corrected visual acuity (BCVA); and central subfield thickness (CST). RESULTS: There was a significant improvement between preopertive and postoperative BCVA when comparing all patients (P values < .0001) and no significant difference in CST before and after surgery (P > .05). There were 23 eyes with fluid on the preoperative OCT. There were no differences in final BCVA or CST and no difference in the development of fluid postoperatively when compared to patients without fluid preoperatively (all P values > .05). These patients also saw a significant improvement in BCVA (P = .006). CONCLUSION: In a real-world setting, patients with both cataracts and wet AMD may safely undergo cataract surgery. Patients with stable preoperative fluid on OCT should be considered for cataract surgery, as these patients did well postoperatively, with no worsening of their neovascular process.
引用
- Starr MR, Mahr MA, Barkmeier AJ, et al. Outcomes of Cataract Surgery in Patients With Exudative Age-related Macular Degeneration and Macular Fluid. Am J Ophthalmol. 2018. PMID: 29802819. doi:10.1016/j.ajo.2018.05.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。